UnitedHealth to Buy Catamaran 

UnitedHealth Group plans to buy Catamaran for about $12.8 billion in cash, bulking up its pharmacy-benefit business. Catamaran shares up 25% premarket; UnitedHealth up 2%.

 
Teva to Acquire Auspex in $3.2 Billion Deal 

Teva Pharmaceutical Industries agreed to acquire Auspex Pharmaceuticals in a deal valued at roughly $3.2 billion, increasing its presence in market for treatments for central nervous system disorders. Auspex shares up 41% premarket.

 
Horizon Pharma to Buy Hyperion Therapeutics 

Horizon Pharma has agreed to purchase Hyperion Therapeutics for $955.7 million in cash, in a move to expand its drug portfolio by adding two treatments for a rare metabolic condition.

 
AIG Raising Up to $507M in PICC Property & Casualty Sale 

American International Group is raising up to US$507 million by selling shares in PICC Property & Casualty in an share placement, according to a term sheet seen by The Wall Street Journal.

 
EU OKs Biomet-Zimmer Deal, Subject to Asset Sales 

Zimmer Holdings secured approval in the European Union for its $13 billion acquisition of fellow orthopedic-device maker Biomet after agreeing to sell three businesses in Europe to assuage antitrust concerns.

 
U.K.'s Biggest Banks Undergo Stress Test 

The U.K.'s biggest banks will be subjected to a severe global economic slowdown and face major difficulty trading assets under the latest Bank of England stress test.

 
Holcim Shareholder Plans to Vote Against Lafarge Deal 

Eurocement Holding, the second-largest shareholder in cement company Holcim, plans to vote against the Swiss company's union with Lafarge unless the financial terms of the deal are altered, according to a person familiar with situation.

 
EIG to Invest in Breitburn 

EIG Global Energy Partners agreed to invest $1 billion in Breitburn Energy Partners, a publicly traded oil and gas exploration and production company, as energy producers turn to alternative capital sources to bolster their balance sheets.